{
  "ticker": "LLY",
  "timestamp": "2025-12-01T08:32:52.520274",
  "analysis_date": "2025-06-25",
  "historical_mode": true,
  "summary": {
    "recommendations": {
      "technical": "BUY",
      "news": "BUY",
      "fundamental": "HOLD",
      "macro": "HOLD"
    },
    "valid_recommendations": {
      "technical": "BUY",
      "news": "BUY",
      "fundamental": "HOLD",
      "macro": "HOLD"
    },
    "confidence_levels": {
      "technical": "Medium",
      "news": "High",
      "fundamental": "Low",
      "macro": "Low"
    },
    "bull_signal_count": 39,
    "bear_signal_count": 7,
    "bull_rec_count": 2,
    "bear_rec_count": 0,
    "hold_rec_count": 2,
    "undetermined_count": 0,
    "analyst_count": 4,
    "valid_analyst_count": 4,
    "net_sentiment": "BULLISH"
  },
  "analyst_summaries": {
    "technical": "TECHNICAL: Uptrend confirmed, RSI 14 \u2192 BUY (Medium)",
    "news": "NEWS: Bullish sentiment (97 articles) \u2192 BUY (High)",
    "fundamental": "FUNDAMENTAL: Mixed fundamentals \u2192 HOLD (Low)",
    "macro": "MACRO: Mixed macro \u2192 HOLD (Low)"
  },
  "full_analyst_reports": {
    "technical": "[TECHNICAL] *** HISTORICAL MODE: Analyzing as of 2025-06-25 ***\n\n======================================================================\nTECHNICAL ANALYSIS: LLY\nAnalysis Period: 7 days\n*** HISTORICAL MODE: As of 2025-06-25 ***\nTimestamp: 2025-12-01 08:31:23\n======================================================================\n\n[TECHNICAL] Fetching 7-day price data for LLY...\n[TECHNICAL] \u2713 Historical: 50 days ending 2025-06-25\n[TECHNICAL]   Date range: 2025-04-14 to 2025-06-25\n[TECHNICAL] \u2713 Retrieved 50 days of data\n[TECHNICAL] Calculating technical indicators...\n[TECHNICAL] \u2713 Indicators calculated\n[TECHNICAL] Identifying support/resistance levels...\n[TECHNICAL] \u2713 Support: $712.13, Resistance: $821.98\n[TECHNICAL] Formatting technical summary...\n[TECHNICAL] Generating analysis with gpt-4o-mini...\n[TECHNICAL] \u274c LLM error: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}\n[TECHNICAL] Creating fallback analysis...\n\n[TECHNICAL] \u2713 Analysis complete in 18.60s\n======================================================================\n\n## Technical Analysis\n*Generated using fallback analysis (LLM unavailable)*\n\n\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-06-25 \u26a0\ufe0f**\nAll data below is historical, ending on 2025-06-25.\nDo NOT reference any price movements or events after this date.\n\n# Technical Analysis Data for LLY\n\n**Analysis Period:** 7 days (Data: 50 days available)\n**Date:** 2025-06-25\n\n## Price Action\n- **Current Price:** $789.40\n- **Period Change:** -1.89%\n- **Day's Range:** $770.77 - $796.03\n- **Volume:** 3,023,100\n- **Volume Assessment:** Normal levels\n\n## Momentum Indicators\n- **RSI(14):** 59.4 \u2192 Neutral zone\n- **MACD:** 6.290 | Signal: 6.317 | Histogram: -0.027\n  \u2192 Bearish momentum \u26a0\ufe0f\n- **Stochastic:** %K=54.6, %D=41.4\n\n## Moving Average Analysis\n- **SMA_5:** $774.91 (Above \u2713)\n- **EMA_10:** $780.62 (Above \u2713)\n- **SMA_20:** $771.54 (Above \u2713)\n- **SMA_50:** $776.81 (Above \u2713)\n\n**Trend:** Strong uptrend (price above all MAs) \u2713\n\n## Volatility & Range\n- **Bollinger Bands:** $713.36 < $789.40 < $829.72\n  \u2192 Middle range (65% position)\n  \u2192 Wide bands (15.1%) - High volatility\n- **ATR:** $19.44 (2.46% of price)\n  \u2192 Normal volatility\n\n## Support & Resistance\n- **Key Resistance:** $821.98\n- **Secondary Resistance:** $821.98\n- **Key Support:** $712.13\n- **Secondary Support:** $714.34\n\n- **Distance to Resistance:** +4.1%\n- **Distance to Support:** +10.9%\n\n## Potential Trade Setup\n- **Setup Type:** LONG\n- **Entry:** $789.40\n- **Stop Loss:** $760.25 (Risk: $29.16)\n- **Target:** $821.98 (Reward: $32.58)\n- **Risk/Reward Ratio:** 1.12:1\n  \u2192 Acceptable risk/reward\n\n\n---\n\n## Automated Assessment\n\n**Signals Detected:** 2 bullish, 0 bearish\n**Reasoning:** Multiple bullish signals: Strong uptrend, Price above MAs\n\nRECOMMENDATION: BUY - Confidence: Medium\n\n",
    "news": "[NEWS] *** HISTORICAL MODE: Analyzing as of 2025-06-25 ***\n\n======================================================================\nNEWS & SENTIMENT ANALYSIS: LLY\n*** HISTORICAL MODE: As of 2025-06-25 ***\nPeriod: Last 7 days | Sources: ['yahoo', 'finnhub']\nTimestamp: 2025-12-01 08:31:44\n======================================================================\n\n[NEWS] \ud83d\udd27 Fetching Yahoo Finance news...\n[NEWS] \u26a0\ufe0f Yahoo Finance has limited historical news support\n[NEWS] \u2713 Yahoo Finance: 0 articles\n[NEWS] \ud83d\udd27 Fetching Finnhub news...\n[NEWS] Finnhub: Fetching news from 2025-06-18 to 2025-06-25\n[NEWS] \u2713 Finnhub: 97 articles\n[NEWS] \ud83d\udccb Enhancing 97 articles with background context\n[NEWS] \u26a0\ufe0f Date 2025-06-25 is past LLM knowledge cutoff (2024-01-01)\n[NEWS] \u26a0\ufe0f Skipping LLM context to prevent hallucination\n[NEWS] Analyzing with gpt-4o-mini...\n[NEWS] \u2713 Analysis complete (2120 chars)\n\n[NEWS] \u2713 Analysis complete in 20.02s\n======================================================================\n\n# News & Sentiment Analysis: LLY\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-06-25 \u26a0\ufe0f**\n**Analysis Period:** Last 7 Days\n**Date:** 2025-12-01 08:31\n\n======================================================================\n\n## Yahoo Finance News (7 Days before 2025-06-25)\n\nNo news found in the specified period\n(Historical mode: news before 2025-06-25)\n## Finnhub News (2025-06-18 to 2025-06-25)\n\n**Found 97 articles**\n\n1. **Buy Eli Lilly While The Market Hesitates And Let Time Make You Dominate**\n   - Source: SeekingAlpha\n   - Published: today\n\n2. **Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity**\n   - Source: Yahoo\n   - Published: today\n   - Viking Therapeutics stock remains under pressure, but analysts said Wednesday the company's strategy for its Phase 3 studies could pay off....\n\n3. **Eli Lilly and Company (LLY) Is Going To Be A \u201cTrillion-Dollar Market Cap,\u201d Says Jim Cramer**\n   - Source: Yahoo\n   - Published: today\n   - Eli Lilly and Company (NYSE:LLY) is one of the Jim Cramer Reveals Potential US Rare Earth Trump Card & Discusses These 11 Stocks. Eli Lilly and Compan...\n\n4. **Novo Nordisk A/S (NVO): \u201cHow Could They Be So Far Behind?,\u201d Wonders Jim Cramer**\n   - Source: Yahoo\n   - Published: today\n   - Novo Nordisk A/S (NYSE:NVO) is one of the Jim Cramer Reveals Potential US Rare Earth Trump Card & Discusses These 11 Stocks. Novo Nordisk A/S (NYSE:NV...\n\n5. **NKTR Stock Soars as Lead Drug Meets Goal in Atopic Dermatitis Study**\n   - Source: Yahoo\n   - Published: today\n   - Nektar's lead candidate, rezpeg, hits key targets in a phase IIb eczema study, sending shares soaring 156.3% on Tuesday....\n\n6. **Novo Nordisk split puts Hims & Hers future in question**\n   - Source: Yahoo\n   - Published: today\n   - Hims & Hers lost a valuable collaboration with Novo Nordisk over compounded GLP-1s. Could it hurt the company's potential to partner with other Big Ph...\n\n7. **Citi bullish on Lilly as Orforglipron unlocks $40B+ obesity market**\n   - Source: Yahoo\n   - Published: today\n   - Investing.com -- Citi reaffirmed its bullish view on Eli Lilly (NYSE:LLY) stock as it sees significant upside from orforglipron, the company\u2019s once-da...\n\n8. **3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow**\n   - Source: Yahoo\n   - Published: today\n   - Eli Lilly is grabbing the lead in the fast-growing diabetes drug market.  Eli Lilly (NYSE: LLY) has been on fire over the past two years.  The drugmak...\n\n\n======================================================================\n\n## News & Sentiment Summary\nEli Lilly (LLY) is experiencing a positive news cycle, with multiple bullish articles highlighting the company's potential in the obesity and diabetes markets. Analysts are optimistic about the future growth prospects, particularly regarding the orforglipron drug, which is seen as a critical player in a lucrative market.\n\n## Key Headlines\n1. **Buy Eli Lilly While The Market Hesitates And Let Time Make You Dominate**\n   - **Impact Assessment:** High potential; suggests long-term investment strategy amidst current market fluctuations.\n\n2. **Eli Lilly and Company (LLY) Is Going To Be A \u201cTrillion-Dollar Market Cap,\u201d Says Jim Cramer**\n   - **Impact Assessment:** High; strong endorsement from a well-known market commentator could attract retail and institutional investors.\n\n3. **Citi bullish on Lilly as Orforglipron unlocks $40B+ obesity market**\n   - **Impact Assessment:** High; significant upside potential highlighted by a reputable financial institution strengthens bullish sentiment.\n\n4. **3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow**\n   - **Impact Assessment:** High; suggests aggressive buying sentiment as the company leads in the diabetes drug market.\n\n## Sentiment Assessment\n- **Overall Sentiment:** Bullish\n- **Sentiment Trend:** Improving\n- **News Volume:** High\n\n## Catalysts Identified\n**Bullish Catalysts:**\n- Positive outlook on orforglipron's market potential.\n- Strong endorsements from analysts and financial commentators.\n- Continued leadership in the diabetes treatment market.\n\n**Bearish Catalysts:** \n- None identified in the recent news cycle.\n\n**Upcoming Events:** \n- No specific upcoming events mentioned, but continuous monitoring of drug approvals and market performance is advisable.\n\n## Trading Implications\nThe current bullish sentiment and strong analyst support suggest that LLY could be a solid investment opportunity. Given the lack of bearish news and the significant upside potential in the obesity and diabetes markets, traders may consider increasing their positions or initiating new ones.\n\nRECOMMENDATION: BUY - Confidence: High\n",
    "fundamental": "[FUNDAMENTALS] *** HISTORICAL MODE: Analyzing as of 2025-06-25 ***\n\n======================================================================\nFUNDAMENTAL ANALYSIS: LLY\n*** HISTORICAL MODE: As of 2025-06-25 ***\nTimestamp: 2025-12-01 08:32:07\n======================================================================\n\n[FUNDAMENTALS] Fetching comprehensive data for LLY...\n[FUNDAMENTALS] \u2713 Comprehensive data retrieved\n[FUNDAMENTALS] Calculating historical metrics for 2025-06-25...\n[FUNDAMENTALS] \u2713 Historical metrics calculated: 4\n[FUNDAMENTALS]   - Price: $789.40\n[FUNDAMENTALS]   - P/E: 86.80\n[FUNDAMENTALS]   - P/B: 44.82\n[FUNDAMENTALS]   - Current Ratio: 1.37\n[FUNDAMENTALS] Analyzing earnings history...\n[FUNDAMENTALS] Filtering earnings to before 2025-06-25\n[FUNDAMENTALS] \u2713 Earnings analysis complete (3/4 beats)\n[FUNDAMENTALS] Fetching SEC 10-K filing data...\n[FUNDAMENTALS] Generating analysis with gpt-4o-mini...\n[FUNDAMENTALS] \u274c LLM error: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}\n\n[FUNDAMENTALS] \u2713 Analysis complete in 19.41s\n======================================================================\n\n## Fundamental Analysis Summary\n*Generated using fallback analysis (LLM unavailable)*\n\n\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-06-25 \u26a0\ufe0f**\nMetrics marked \"N/A\" could not be calculated historically - ignore them in your analysis.\nOnly analyze metrics with actual values.\n\n# Fundamental Data for LLY\n\n## Company Information\n- **Name:** Eli Lilly and Company\n- **Sector:** Healthcare\n- **Industry:** Drug Manufacturers - General\n\n## Current Price\n- **Price:** $789.40\n- **52-Week High:** $1111.99\n- **52-Week Low:** $623.78\n\n## Valuation Metrics\n- **Market Cap:** $964.11B\n- **Enterprise Value:** $995.68B\n- **Trailing P/E:** 86.80\n- **Forward P/E:** N/A (historical - forward-looking)\n- **PEG Ratio:** N/A (historical)\n- **Price/Book:** 44.82\n- **Price/Sales:** 16.23\n- **EV/Revenue:** 16.76\n- **EV/EBITDA:** 34.66\n\n## Growth Metrics\n- **Revenue Growth:** 53.9%\n- **Earnings Growth:** 480.4%\n- **Quarterly Revenue Growth:** N/A\n- **Quarterly Earnings Growth:** N/A\n\n## Profitability\n- **Profit Margin:** 31.0%\n- **Operating Margin:** 48.3%\n- **Gross Margin:** 83.0%\n- **ROE:** 96.5%\n- **ROA:** 17.6%\n\n## Financial Health\n- **Current Ratio:** 1.37\n- **Quick Ratio:** 0.72\n- **Debt/Equity:** 178.52\n- **Total Cash:** $9.91B\n- **Total Debt:** $42.58B\n- **Free Cash Flow:** $1.40B\n\n## Analyst Opinions\n- **Recommendation:** BUY\n- **Number of Analysts:** 27\n- **Target (Mean):** $1024.00\n- **Target (High):** $1500.00\n- **Target (Low):** $770.00\n- **Implied Upside:** -4.8%\n\n## Earnings History (Last 4 Quarters)\n- Unknown: Actual $5.32 vs Est $5.07 (+5.0%) \u2713 Beat\n- Unknown: Actual $3.34 vs Est $3.54 (-5.7%) \u2717 Miss\n- Unknown: Actual $6.31 vs Est $5.59 (+12.9%) \u2713 Beat\n- Unknown: Actual $7.02 vs Est $5.89 (+19.2%) \u2713 Beat\n\n**Summary:** Beat Rate: 75%, Trend: Declining, Quality: Strong\n\n\n\nRECOMMENDATION: HOLD - Confidence: Low\n\n",
    "macro": "[MACRO] *** HISTORICAL MODE: Analyzing as of 2025-06-25 ***\n\n======================================================================\nMACRO ECONOMIC ANALYSIS\nPeriod: 7 days | Sector: All\n*** HISTORICAL MODE: As of 2025-06-25 ***\nTimestamp: 2025-12-01 08:32:28\n======================================================================\n\n[MACRO] Starting iterative analysis...\n[MACRO] Iteration 1/10\n[MACRO] \ud83d\udd27 Executing: get_market_indicators\n[MACRO] \ud83d\udd27 Tool: get_market_indicators (days=7)\n[MACRO] \u2713 Fetched 6/6 indicators\n[MACRO] \ud83d\udd27 Executing: get_sector_performance\n[MACRO] \ud83d\udd27 Tool: get_sector_performance (days=7)\n[MACRO] \u2713 Analyzed 9/9 sectors\n[MACRO] \ud83d\udd27 Executing: get_economic_indicators\n[MACRO] \ud83d\udd27 Tool: get_economic_indicators (days=7)\n[MACRO] \u2713 Economic indicators retrieved\n[MACRO] \ud83d\udd27 Executing: get_market_breadth\n[MACRO] \ud83d\udd27 Tool: get_market_breadth (days=7)\n[MACRO] \u2713 Breadth analysis complete\n[MACRO] Iteration 2/10\n[MACRO] \u274c Error in iterative analysis: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}\n\n[MACRO] \u2713 Complete in 23.67s\n======================================================================\n\n# Macro Analysis (Partial)\n*Analysis Period: 7 days*\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-06-25**\n*Successful Tools: 4, Failed: 0*\n\nRaw data gathered successfully:\n\nTools executed: get_market_indicators, get_sector_performance, get_economic_indicators, get_market_breadth\n\nRECOMMENDATION: NEUTRAL - Confidence: Low (Partial data)\n\n"
  },
  "bull_evidence": [
    {
      "source": "technical",
      "signal": "**Reasoning:** Multiple bullish signals: Strong uptrend, Price above MAs",
      "strength": 2,
      "keywords_matched": 2
    },
    {
      "source": "technical",
      "signal": "[TECHNICAL] \u2713 Support: $712",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "## Momentum Indicators",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "**Trend:** Strong uptrend (price above all MAs) \u2713",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Key Support:** $712",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Secondary Support:** $714",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Distance to Support:** +10",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "RECOMMENDATION: BUY - Confidence: Medium",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "- **Impact Assessment:** High; significant upside potential highlighted by a reputable financial institution strengthens bullish sentiment",
      "strength": 3,
      "keywords_matched": 3
    },
    {
      "source": "news",
      "signal": "The current bullish sentiment and strong analyst support suggest that LLY could be a solid investment opportunity",
      "strength": 3,
      "keywords_matched": 3
    },
    {
      "source": "news",
      "signal": "com -- Citi reaffirmed its bullish view on Eli Lilly (NYSE:LLY) stock as it sees significant upside from orforglipron, the company\u2019s once-da",
      "strength": 2,
      "keywords_matched": 2
    },
    {
      "source": "news",
      "signal": "Eli Lilly (LLY) is experiencing a positive news cycle, with multiple bullish articles highlighting the company's potential in the obesity and diabetes markets",
      "strength": 2,
      "keywords_matched": 2
    },
    {
      "source": "news",
      "signal": "[NEWS] \u26a0\ufe0f Yahoo Finance has limited historical news support",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Buy Eli Lilly While The Market Hesitates And Let Time Make You Dominate**",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Citi bullish on Lilly as Orforglipron unlocks $40B+ obesity market**",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow**",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "Analysts are optimistic about the future growth prospects, particularly regarding the orforglipron drug, which is seen as a critical player in a lucrative market",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Buy Eli Lilly While The Market Hesitates And Let Time Make You Dominate**",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "- **Impact Assessment:** High; strong endorsement from a well-known market commentator could attract retail and institutional investors",
      "strength": 1,
      "keywords_matched": 1
    }
  ],
  "bear_evidence": [
    {
      "source": "technical",
      "signal": "13, Resistance: $821",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Key Resistance:** $821",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Secondary Resistance:** $821",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Distance to Resistance:** +4",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Risk/Reward Ratio:** 1",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "\u2192 Acceptable risk/reward",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Bearish Catalysts:**",
      "strength": 1,
      "keywords_matched": 1
    }
  ],
  "key_conflicts": [
    {
      "type": "recommendation_conflict",
      "severity": "MINOR",
      "analysts": [
        "fundamental",
        "technical"
      ],
      "positions": {
        "fundamental": "HOLD",
        "technical": "BUY"
      },
      "description": "fundamental says HOLD while technical says BUY"
    },
    {
      "type": "recommendation_conflict",
      "severity": "MINOR",
      "analysts": [
        "fundamental",
        "news"
      ],
      "positions": {
        "fundamental": "HOLD",
        "news": "BUY"
      },
      "description": "fundamental says HOLD while news says BUY"
    },
    {
      "type": "recommendation_conflict",
      "severity": "MINOR",
      "analysts": [
        "macro",
        "technical"
      ],
      "positions": {
        "macro": "HOLD",
        "technical": "BUY"
      },
      "description": "macro says HOLD while technical says BUY"
    },
    {
      "type": "recommendation_conflict",
      "severity": "MINOR",
      "analysts": [
        "macro",
        "news"
      ],
      "positions": {
        "macro": "HOLD",
        "news": "BUY"
      },
      "description": "macro says HOLD while news says BUY"
    }
  ],
  "consensus_points": [
    {
      "type": "partial_consensus",
      "recommendation": "BUY",
      "count": 2,
      "analysts": [
        "technical",
        "news"
      ],
      "description": "Partial consensus: technical and news both say BUY"
    },
    {
      "type": "partial_consensus",
      "recommendation": "HOLD",
      "count": 2,
      "analysts": [
        "fundamental",
        "macro"
      ],
      "description": "Partial consensus: fundamental and macro both say HOLD"
    }
  ],
  "research_priorities": [
    {
      "priority": "HIGH",
      "focus": "validate_bull_thesis",
      "description": "Strong bullish bias (39 vs 7 signals)",
      "action": "Validate assumptions - could be herd mentality or overlooked risks"
    },
    {
      "priority": "URGENT",
      "focus": "time_sensitive_event",
      "description": "Upcoming catalyst detected",
      "signal": "**3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow**",
      "source": "news",
      "action": "Research before event occurs"
    }
  ],
  "analyst_reports_summary": {
    "technical": {
      "recommendation": "BUY",
      "confidence": "Medium",
      "report_length": 3068,
      "has_data": true,
      "completed_successfully": true
    },
    "news": {
      "recommendation": "BUY",
      "confidence": "High",
      "report_length": 5636,
      "has_data": true,
      "completed_successfully": true
    },
    "fundamental": {
      "recommendation": "HOLD",
      "confidence": "Low",
      "report_length": 3232,
      "has_data": true,
      "completed_successfully": true
    },
    "macro": {
      "recommendation": "HOLD",
      "confidence": "Low",
      "report_length": 1737,
      "has_data": true,
      "completed_successfully": true
    }
  },
  "data_quality": {
    "status": "COMPLETE",
    "total_analysts": 4,
    "valid_analysts": 4,
    "failed_analysts": 0,
    "failed_list": [],
    "note": null
  },
  "llm_synthesis": "Synthesis error: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}",
  "synthesis_direction": "UNDETERMINED",
  "synthesis_confidence": "N/A"
}